Neurocritical Care News

Topcon Healthcare has partnered with Microsoft Corp. to create “Healthcare from the Eye,” an AI-powered solution developed to improve health care by prescreening patients for systemic and neurological diseases via a noninvasive eye scan.

The FDA has granted breakthrough therapy designation to a proprietary oligonucleotide conjugate for the treatment of myotonic dystrophy type 1, according to the manufacturer.

For patients diagnosed with intracerebral hemorrhage, surgical intervention within 24 hours led to better functional outcomes at 180 days compared with medical management alone, researchers wrote in the New England Journal of Medicine.

DENVER — Experiences and concerns about treatment, diagnosis, care, cost and quality of life among Black and Hispanic patients with myasthenia gravis were more negative compared with their Asian and white counterparts, according to research.

DENVER — Losmapimod treatment for those with facioscapulohumeral muscular dystrophy led to no serious adverse events across three clinical trials, according to a poster at the American Academy of Neurology annual meeting.

Among adolescents with focal epilepsy, nonmotor seizures are more often missed or misdiagnosed compared with motor seizures, according to research presented in Neurology.

DENVER — A panel of four experts discussed different aspects of the ways brain health and climate change are linked at the American Academy of Neurology annual meeting.

DENVER — Uncontrolled generalized myasthenia negatively affects patients’ mental health, which in turn negatively impacts their physical symptoms, according to a poster presentation at the American Academy of Neurology annual meeting.

A Bay Area biopharmaceutical firm has announced positive results from its phase 1 clinical trial in healthy volunteers of a novel PDE4 inhibitor being developed to treat those with cognitive impairment associated with schizophrenia.

Wearable accelerometers may be a reliable tool to track disease progression in patients with amyotrophic lateral sclerosis, researchers wrote in The Lancet.